Expert Interviews

November 27, 2020

Jeffrey Curtis, MD, MS, MPH, details how the perception of biphosphonates has been detrimental to efforts to improve treatment and diagnosis of osteoporosis.

November 24, 2020

An endocrinologist from Brigham and Women’s Hospital discusses the latest in diabetes management.

November 24, 2020

Jeffrey Curtis, MD, MS, MPH, offers his thoughts on the most effective methods to address the underdiagnosis and undertreatment of osteoporosis in older male patients.

November 18, 2020

A cardiologist from Brigham and Women's Hospital offers his thoughts on the results of phase 3 SCORED and SOLOIST trials, which examined use of sotagliflozin in patients with type 2 diabetes.

November 16, 2020

Professor John McMurray explains why he is not as displeased as some colleagues are with the uptake of SGLT2 inhibitor prescribing rates for patients with heart failure or chronic kidney disease.

November 14, 2020

In honor of World Diabetes Day, we reached out to Lucia Novak, CRNP, to get her perspective on the role of nurses in the diabetes care model as "The Nurse and Diabetes" has been chosen as the official theme of this year's World Diabetes Day.

November 09, 2020

A nephrologist and professor from the University of Toronto offers insight into the results of a key kidney outcomes analysis of the VERTIS-CV trial.

October 26, 2020

The Assistant Dean of Community Engagement at the School of Nursing at the University of Pennsylvania offers perspective on addressing racial and ethnic disparities in medicine at an individual and societal level.

October 05, 2020

Muthiah Vaduganathan, MD, MPH, of Brigham and Women's discusses the barriers to preventing optimal prescribing practices for SGLT2 inhibitor and GLP-1 receptor agonist therapies.

September 28, 2020

An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.